A detailed history of New Century Advisors, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, New Century Advisors, LLC holds 893 shares of UTHR stock, worth $333,955. This represents 0.23% of its overall portfolio holdings.

Number of Shares
893
Previous 1,069 16.46%
Holding current value
$333,955
Previous $252,000 25.79%
% of portfolio
0.23%
Previous 0.29%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 13, 2022

SELL
$203.3 - $244.17 $35,780 - $42,973
-176 Reduced 16.46%
893 $187,000
Q2 2022

Jul 15, 2022

BUY
$174.81 - $241.14 $10,838 - $14,950
62 Added 6.16%
1,069 $252,000
Q1 2022

Apr 21, 2022

BUY
$166.16 - $213.96 $32,567 - $41,936
196 Added 24.17%
1,007 $180,000
Q4 2021

Feb 04, 2022

BUY
$184.32 - $216.08 $149,483 - $175,240
811 New
811 $175,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $17B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track New Century Advisors, LLC Portfolio

Follow New Century Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Century Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Century Advisors, LLC with notifications on news.